BEAT Shares Outstanding History
Below is a table of the BEAT shares outstanding history going back to 2/10/2010:

Date BEAT Shares Outstanding
2/10/201023.96M
4/23/201024.12M
7/30/201024.13M
9/20/201024.13M
11/1/201024.23M
2/14/201124.26M
4/25/201124.37M
8/1/201124.40M
11/4/201124.52M
2/16/201224.55M
5/2/201224.94M
8/2/201224.92M
10/31/201225.15M
2/13/201325.22M
4/25/201325.38M
11/4/201325.76M
2/24/201426.04M
5/2/201426.39M
7/29/201426.46M
10/28/201426.68M
2/18/201526.73M
5/4/201527.05M
8/3/201527.12M
11/4/201527.26M
2/17/201627.39M
4/22/201627.89M
7/26/201628.03M
10/28/201628.23M
2/17/201728.37M
4/26/201728.66M
8/1/201732.36M
11/1/201732.41M
2/15/201832.53M
4/19/201832.79M
7/16/201832.72M
10/15/201833.30M
2/5/201933.61M
4/22/201933.80M
7/22/201933.89M
2/21/201837.96M
10/28/201933.99M
2/17/202034.02M
4/30/202034.14M
7/24/202034.19M
10/23/202034.26M

Also see: BEAT Market Cap History
BEAT YTD Return
BEAT Historical Shares Outstanding:
+3.40% CAGR
BEAT Historical Shares Outstanding: +3.40% CAGR

Mouse over chart for data details
2/10/2010 ...10/23/2020
BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, centralized core laboratory services, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. Co.'s segments are: Healthcare, which is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices; and Research, which is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, consulting and data management services for drug and medical device trials. We show 45 historical shares outstanding datapoints in our coverage of BEAT's shares outstanding history.

Understanding the changing numbers of BEAT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BEAT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BEAT by allowing them to research BEAT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree BEAT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BioTelemetry (BEAT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BFLY Shares Outstanding History
BHG Shares Outstanding History
BIIB Shares Outstanding History
BIO Shares Outstanding History
BIOC Shares Outstanding History
BIOL Shares Outstanding History
BIOS Shares Outstanding History
BIVI Shares Outstanding History
BKD Shares Outstanding History
BLCM Shares Outstanding History
More Healthcare companies »

 

BEAT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.